OncoGenex
Bothell
About OncoGenex
OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $84.3M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2012)
- Ticker: nasdaq:OGXI
- Website: oncogenex.com
- Phone: 4256861500
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/oncogenex-1738192 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.